GeoVax Discloses Finance and Medical Leadership Changes

Company GeoVax Labs Event Type CFO resignation and CMO termination (SEC 8-K, recovered 19 Nov filing) Modality Not applicable (MVA-vectored vaccines and immunotherapies) Asset Not applicable Target Not applicable Disease Area Vaccines and immunotherapy Summary GeoVax filed a cluster of leadership changes on November 19:…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *